InvestorsHub Logo

Noemotionseller

01/27/16 4:17 PM

#30812 RE: Bristol19 #30811

I just CAN NOT imagine that it has anything to do with buyout mergers. The companies buying/merging are very savvy and KNOW what good technology is. They will have done their DD and have market feedback... TRXC IMO is just pathetic.... It is an expensive intrusive laparoscopic device with no advantage over current convenience...
I think that ISRG has performed really well in the midst of a market correction... Medical robotics has a significant future and the articles of late are recognizing all players. Investors are looking for positive areas to put the money. TRXC is in the right place at the right time for recognition as an investment opportunity. NON-Medical Wall Street is throwing money at a next best bet... Titan is too far away for them and we are trading OTC... TRXC is perceived to be more legit and is "next" to compete with ISRG. The problem may not be so good for us... WE KNOW that TRXC sucks... It will have moderate sales at best, but no where near emulating the success of ISRG. Investment firms may get burned by it.... If they get burned, they will be licking their wounds when it comes time for the next "no name" competitor entering the ring. TRXC could deaden the excitement for SPORT in the investment community to an extent... I hope I am wrong, and they both cause the Robotic Race with BO/Mergers and we get a meteoric rise. It is going to be interesting to watch, however, I am getting tired of watching and want some return on my investment!!

SPORT19

01/27/16 4:46 PM

#30814 RE: Bristol19 #30811

ALF might be a marketable option for them but I would think that using a million $+ device as a jumpstart into the market might not be a good idea. You need to be committed to something like ALF for a long term. Can't have your sales force selling ALF and then turn around and start selling something "better" soon after IMO.